Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer TNBC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04606472
What this trial is testing

SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 60
Early research (Phase 1)Looking for participantsNCT06545331
What this trial is testing

Study of XB010 in Subjects With Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid TumorsEsophageal Squamous Cell CancerHead and Neck Squamous Cell Cancer+3 more
Exelixis 396
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Very early researchWithdrawnNCT06246786
What this trial is testing

Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)

Who this might be right for
Triple Negative Breast CancerDNA Damage Repair Deficiency
Virginia G. Kaklamani
Early research (Phase 1)Looking for participantsNCT05005403
What this trial is testing

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Who this might be right for
Non-Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaMicro Satellite Stable Colorectal Cancer+4 more
AbbVie
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808662
What this trial is testing

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Who this might be right for
TNBC - Triple-Negative Breast CancerTriple Negative Breast CancerNSCLC+4 more
Memorial Sloan Kettering Cancer Center 107
Testing effectiveness (Phase 2)Looking for participantsNCT06831955
What this trial is testing

LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer (TNBC), Early Setting
Universitaire Ziekenhuizen KU Leuven 356
Not applicableWithdrawnNCT06610097
What this trial is testing

TNBC Gut Microbiota During Neoadjuvant Treatment

Who this might be right for
Breast CancerTriple Negative Breast CancerEarly Stage Triple-Negative Breast Carcinoma
Scripps Health
Testing effectiveness (Phase 2)Looking for participantsNCT06817525
What this trial is testing

Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC

Who this might be right for
Triple-negative Breast Cancer
Henan Cancer Hospital 64
Testing effectiveness (Phase 2)UnknownNCT05834582
What this trial is testing

Neoadjuvant Fluzoparib in Germline BRCA-mutated Three-negative Breast Cancer Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 60
Testing effectiveness (Phase 2)Study completedNCT05520723
What this trial is testing

Preventive stRategy for IMMU132-relatED AEs in TNBC or Luminal Breast Cancer- PRIMED

Who this might be right for
Triple Negative Breast CancerBreast CancerAdvanced HR+/HER2- Breast Cancer
MedSIR 50
Testing effectiveness (Phase 2)UnknownNCT04676997
What this trial is testing

Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC)

Who this might be right for
Triple Negative Breast Cancer
Shandong Cancer Hospital and Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT04916002
What this trial is testing

A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer

Who this might be right for
Merkel Cell CarcinomaCutaneous Squamous Cell CarcinomaBasal Cell Carcinoma+3 more
Regeneron Pharmaceuticals 77
Early research (Phase 1)Active Not RecruitingNCT06036121
What this trial is testing

ADRX-0706 in Select Advanced Solid Tumors

Who this might be right for
Solid TumorsTriple Negative Breast Cancer (TNBC)Urothelial Cancer+1 more
Adcentrx Therapeutics 144
Testing effectiveness (Phase 2)Active Not RecruitingNCT05933265
What this trial is testing

Study of LP-184 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorGBM+4 more
Lantern Pharma Inc. 64
Testing effectiveness (Phase 2)Looking for participantsNCT06387628
What this trial is testing

LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 74
Not applicableUnknownNCT05586659
What this trial is testing

Epidemiology of TNBC in Asyut Clinical Oncology Department

Who this might be right for
Breast Cancer
Assiut University 50
Early research (Phase 1)UnknownNCT03855358
What this trial is testing

TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC)

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 30
Early research (Phase 1)Ended earlyNCT03199040
What this trial is testing

Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy

Who this might be right for
Triple Negative Breast CancerTriple Negative Breast NeoplasmsTNBC - Triple-Negative Breast Cancer+1 more
Washington University School of Medicine 18
Testing effectiveness (Phase 2)Looking for participantsNCT06793332
What this trial is testing

BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC

Who this might be right for
Triple-Negative Breast Cancer (TNBC)Brain Metastases
Fudan University 39
Next Page
694